|
|
||||||||
|
|
|||||||||
|
|
Oncology-Clinical Diagnosis: Solid TumorsLung Cancer II |
1 Radiology, The Catholic University of Korea, Seoul, South Korea
225
Objectives: Small indeterminate pulmonary nodules with little or no 18F-FDG uptake present as diagnostic challenge on PET/CT images of lung cancer patients, and this study evaluates the significance of these nodules.
Methods: 817 PET/CT studies of lung cancer patients from November 2003 to April 2007 were reviewed. In 43 patients, in addition to the primary tumor, there were pulmonary nodules less than 1 cm in diameter showing little or no 18F-FDG uptake. Nodules with findings indicative of benign nature or malignancy were excluded. All 43 cases had pathologic confirmation or clinical follow-up with enhanced chest CT. The 43 cases were subdivided into four categories: (1) number of nodules (solitary or multiple); (2) presence or absence of other accompanying benign lung abnormalities; (3) presence or absence of perceptible FDG uptake; (4) and location of the nodule (same lobe, ipsilateral lung, or contralateral lung). The incidence of malignancy was calculated for each group of the four categories.
Results: Of the 43 cases, 5 (11.6%) were confirmed to be malignant nodules. No statistically meaningful difference was noted between the solitary and multiple nodule groups (4.2% versus 21.1%), the groups with and without accompanying lung lesions (8.3% vs. 12.9%), the faint FDG uptake group and imperceptible group (16.7% vs. 10.8%), or the groups by the site of nodule (same lobe 7.7%, ipsilateral lung 14.3%, contralateral lung 12.5%).
Conclusions: Small lung nodules with no or faint FDG uptake in lung cancer patients were malignant in over 11% of the cases. Thus, when small indeterminate pulmonary nodules are present in lung cancer patients close follow-up is mandatory, regardless of their number, presence of accompanying benign lesion, degree of FDG uptake, or location.
| ||||||||||||||||||||||||||||||||||||||